Clinical trial
Phase II Study of Inhaled CO for the Treatment of Idiopathic Pulmonary Fibrosis
NCT01214187 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Inhaled CO for the Treatment of Idiopathic Pulmonary Fibrosis
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- April 30, 2015
- Enrollment
- 58 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.